ProQR Analyst Event

Add to calender
Investor
ProQR logo with text: ProQR Analyst Event November 18, 2021. Image of RNA and Maartje, living with Usher syndrome

The live and archived webcast will be accessible through this webcast link.

Download the presentation

Program

Welcome

Sarah Kiely, VP IR & Corporate Communications

Vision and Strategy

Daniel A. de Boer, Chief Executive Officer

Clinical Programs

Aniz Girach, MD, Chief Medical Officer

RNA Toolbox

Gerard Platenburg, Chief Innovation Officer

Q&A

moderated by Smital Shah, Chief Business & Financial Officer

You might like this

  • Press releases

    Read the latest news on our development programs, business updates and announcements. You can sign up for email alerts so you stay up to date on all things ProQR.

    Female scientist working in ProQR's laboratories

  • Our science

    Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments for people with genetic diseases.

    Axiomer RNA editing platform technology

  • About ProQR Therapeutics

    ProQR was founded by Daniel de Boer with a mission to help people living with rare genetic diseases. This remains the sole focus of our company today.

    Daniel de Boer wearing a blue suit stands with arm crossed in a laboratory setting.